Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
731 17 |
Ultima descărcare din IBN: 2024-03-30 21:53 |
Căutarea după subiecte similare conform CZU |
618.146-006.6-073 (1) |
Științe medicale. Medicină (11142) |
SM ISO690:2012 CODREANU, Nadejda, MURŞIEV, Cristina, BOTNARI-GUȚU, Mihaela, RUSNAC, Diana, BAHOVA, Elena. Rolul testarii la HPV în managementul contemporan al stărilor precanceroase și cancerului colului uterin. In: Buletin de Perinatologie, 2019, nr. 1(82), pp. 16-21. ISSN 1810-5289. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Buletin de Perinatologie | ||||||
Numărul 1(82) / 2019 / ISSN 1810-5289 | ||||||
|
||||||
CZU: 618.146-006.6-073 | ||||||
Pag. 16-21 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Background: Cervical cancer aff ects about 500.000 women each year, having serious repercussions upon the public health, as half of the primary diagnosed cases are lethal. Th e statistics show that 91% of women survive at least for 5 years aft er the diagnosis is established, assuming that it is a early stage. Great progress in the prevention, diagnosis and treatment of cervical cancer has been obtained since the cytological screening, HPV genotipation and anti-HPV vaccination have been discovered, as the lethality dropped by 80%. But in spite of this fact, it is important to keep in mind that the Pap-test has its clinical limitations, as about 1/3 of the precancerous lesions remain underdiagnosed. Recently, the studies performed for the US Cancer prevention Center showed that the HPV testing has a greater sensitivity in detecting ≥CIN2 and ≥CIN3 lesions versus the pap-smear. Th e HPV testing off ers the possibility to quantify the risk , the sensitivity Cobas® HPV Test being with about 35,7% higher and reaching about 100%. In our study, only 1 of 10 women with positive HPV 16, 18 had precancerous cervical modifi cations and normal cytological results. Th e aim of the study was to evaluate the role of the HPV testing in the contemporary screening and management of the precancerous and cancerous cervical modifi cations. Materials and methods: Th e study was based on the data of 270 women of 18-60 years of age. Th eir Pap-smear and HPV-AND tests were performed in the Synevo-Laboratory. Based on this results the women were redirected for colposcopy and onco-gynecological consultations, including biopsy and treatment. |
||||||
Cuvinte-cheie HPV screening, cervical cancer, cervical precancerous lesions, ВПЧ скрининг, предраковая и раковая патология шейки матки |
||||||
|